躁うつ病としても知られる双極性障害は、精神疾患です。主に気分に影響を与えるのはメンタルヘルスの問題です。双極性障害の症状は、極度の過敏性または興奮、空虚感の期間、通常の活動への興味の喪失、睡眠障害などです。Pfizer、Inc。によると、双極性障害は米国の500万人以上に影響を及ぼします。行動と気分の劇的な変化であり、喜びと興奮（躁うつ病）から非常に悲しくて絶望的な（抑うつ状態）までさまざまです。これらの障害には、躁病エピソード、軽躁病エピソード、うつ病エピソード、混合エピソードなど、さまざまなタイプのエピソードがあります。双極性障害の原因には、小児期のトラウマ、ストレスの多いライフイベント、自尊心の問題、遺伝的遺伝などがあります。世界中の人々が「3月30日」を世界双極性障害の日としてマークし、障害についての認識を広め、精神疾患の汚名を消しました。この精神状態に苦しむ多くの人々は、気分を高揚させるために飲酒に頼っています。 National Institute on Alcohol Abuse and Alcoholismによると、双極性障害を持つ人々の27.6％がアルコール中毒になり、16％以上がアルコール乱用に従事しています。
双極性障害の経済的負担を軽減する必要性の高まりは、2021年末まで世界の双極性障害治療市場の成長見通しを後押しします。世界中の政府や企業が、病気の認識を高めるために意識向上キャンプをますます組織していることが観察されています。公衆は、脆弱なグループの精神障害の負担を軽減し、精神障害を持つ人々の権利を確保し、治療施設を彼らが利用できるようにします。その結果、そのような意識向上イニシアチブは、全体的な金銭的損失を抑制し、世界経済への影響を減らし、患者の生活の質を改善するのに役立ちます。そのような要因は、精神障害と治療についての一般の認識を高め、ひいては、市場での収益創出率を推進します。
南北アメリカは2016年に市場シェアの過半数を占め、予測期間中も市場を支配し続けるでしょう。この地域の市場の成長の主な要因のいくつかは、米国での双極性障害の症状の発生率の高さ、パイプライン製品の数の増加、この地域でのこれらの障害に対する意識の高まり、および小児双極性障害の有病率の増加です。 。
まとめグローバル双極性障害治療市場は、2015年から2019年までのCAGR xx％でxxx百万米ドルと評価されました。 その後、2020年にはXXX百万米ドルに達し、2020年から2025年までのCAGRはxx％になります。
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Bipolar Disorder Therapeutic Market Size Growth Rate by Type (2020-2025)
1.3.2 Antipsychotics
1.3.3 Anticonvulsants
1.3.4 Mood Stabilizers
1.4 Market Segment by Application
1.4.1 Global Bipolar Disorder Therapeutic Market Share by Application (2020-2025)
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bipolar Disorder Therapeutic Market Size
2.1.1 Global Bipolar Disorder Therapeutic Revenue 2015-2025
2.1.2 Global Bipolar Disorder Therapeutic Sales 2015-2025
2.2 Bipolar Disorder Therapeutic Growth Rate by Regions
2.2.1 Global Bipolar Disorder Therapeutic Sales by Regions 2015-2019
2.2.2 Global Bipolar Disorder Therapeutic Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Bipolar Disorder Therapeutic Sales by Manufacturers
3.1.1 Bipolar Disorder Therapeutic Sales by Manufacturers 2015-2019
3.1.2 Bipolar Disorder Therapeutic Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Bipolar Disorder Therapeutic Revenue by Manufacturers (2015-2019)
3.2.2 Bipolar Disorder Therapeutic Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Bipolar Disorder Therapeutic Market Concentration Ratio (CR5 and HHI)
3.3 Bipolar Disorder Therapeutic Price by Manufacturers
3.4 Key Manufacturers Bipolar Disorder Therapeutic Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Bipolar Disorder Therapeutic Market
3.6 Key Manufacturers Bipolar Disorder Therapeutic Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Antipsychotics Sales and Revenue (2015-2019)
4.1.2 Anticonvulsants Sales and Revenue (2015-2019)
4.1.3 Mood Stabilizers Sales and Revenue (2015-2019)
4.2 Global Bipolar Disorder Therapeutic Sales Market Share by Type
4.3 Global Bipolar Disorder Therapeutic Revenue Market Share by Type
4.4 Bipolar Disorder Therapeutic Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Bipolar Disorder Therapeutic Sales by Application
6 United States
6.1 United States Bipolar Disorder Therapeutic Breakdown Data by Company
6.2 United States Bipolar Disorder Therapeutic Breakdown Data by Type
6.3 United States Bipolar Disorder Therapeutic Breakdown Data by Application
7 European Union
7.1 European Union Bipolar Disorder Therapeutic Breakdown Data by Company
7.2 European Union Bipolar Disorder Therapeutic Breakdown Data by Type
7.3 European Union Bipolar Disorder Therapeutic Breakdown Data by Application
8 China
8.1 China Bipolar Disorder Therapeutic Breakdown Data by Company
8.2 China Bipolar Disorder Therapeutic Breakdown Data by Type
8.3 China Bipolar Disorder Therapeutic Breakdown Data by Application
9 Rest of World
9.1 Rest of World Bipolar Disorder Therapeutic Breakdown Data by Company
9.2 Rest of World Bipolar Disorder Therapeutic Breakdown Data by Type
9.3 Rest of World Bipolar Disorder Therapeutic Breakdown Data by Application
9.4 Rest of World Bipolar Disorder Therapeutic Breakdown Data by Countries
9.4.1 Rest of World Bipolar Disorder Therapeutic Sales by Countries
9.4.2 Rest of World Bipolar Disorder Therapeutic Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Eli Lilly
10.1.1 Eli Lilly Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Bipolar Disorder Therapeutic
10.1.4 Bipolar Disorder Therapeutic Product Introduction
10.1.5 Eli Lilly Recent Development
10.2 Bristol-Myers Squibb
10.2.1 Bristol-Myers Squibb Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Bipolar Disorder Therapeutic
10.2.4 Bipolar Disorder Therapeutic Product Introduction
10.2.5 Bristol-Myers Squibb Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Bipolar Disorder Therapeutic
10.3.4 Bipolar Disorder Therapeutic Product Introduction
10.3.5 AstraZeneca Recent Development
10.4 Allergan
10.4.1 Allergan Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Bipolar Disorder Therapeutic
10.4.4 Bipolar Disorder Therapeutic Product Introduction
10.4.5 Allergan Recent Development
10.5 Astellas Pharma
10.5.1 Astellas Pharma Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Bipolar Disorder Therapeutic
10.5.4 Bipolar Disorder Therapeutic Product Introduction
10.5.5 Astellas Pharma Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Bipolar Disorder Therapeutic
10.6.4 Bipolar Disorder Therapeutic Product Introduction
10.6.5 GlaxoSmithKline Recent Development
10.7 Janssen Pharmaceuticals
10.7.1 Janssen Pharmaceuticals Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Bipolar Disorder Therapeutic
10.7.4 Bipolar Disorder Therapeutic Product Introduction
10.7.5 Janssen Pharmaceuticals Recent Development
12 Market Forecast
12.1 Global Bipolar Disorder Therapeutic Sales and Revenue Forecast 2020-2025
12.2 Global Bipolar Disorder Therapeutic Sales Forecast by Type
12.3 Global Bipolar Disorder Therapeutic Sales Forecast by Application
12.4 Bipolar Disorder Therapeutic Forecast by Regions
12.4.1 Global Bipolar Disorder Therapeutic Sales Forecast by Regions 2020-2025
12.4.2 Global Bipolar Disorder Therapeutic Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
